News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
552,178 Results
Type
Article (15088)
Company Profile (151)
Press Release (537000)
Multimedia
Podcasts (6)
Webinars (11)
Section
Business (183348)
Career Advice (463)
Deals (28248)
Drug Delivery (18)
Drug Development (55457)
Employer Resources (23)
FDA (12861)
Job Trends (10088)
News (263821)
Policy (22287)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (840)
Accelerated approval (26)
ADA (21)
Adcomms (2)
Allergies (120)
Alliances (37158)
ALS (108)
Alzheimer's disease (1091)
Antibody-drug conjugate (ADC) (290)
Approvals (13557)
Artificial intelligence (422)
ASCO (170)
Autoimmune disease (221)
Automation (36)
Bankruptcy (281)
Best Places to Work (7855)
BIO (36)
Biologics (3)
BIOSECURE Act (1)
Biosimilars (124)
BioSpace Insights (32)
Biotechnology (93)
Bladder cancer (144)
Brain cancer (37)
Breast cancer (547)
Cancer (3968)
Cardiovascular disease (277)
Career advice (393)
Career pathing (5)
CAR-T (178)
CDC (2)
Celiac Disease (1)
Cell therapy (508)
Cervical cancer (42)
Clinical research (50226)
Collaboration (1384)
Commercialization (4)
Company closure (2)
Compensation (1478)
Complete response letters (41)
COVID-19 (904)
CRISPR (63)
C-suite (849)
Cystic fibrosis (89)
Data (6161)
Decentralized trials (1)
Denatured (5)
Depression (118)
Dermatology (67)
Diabetes (430)
Diagnostics (4905)
Digital health (54)
Diversity (2)
Diversity, equity & inclusion (8)
Drug discovery (168)
Drug pricing (12)
Drug shortages (5)
Duchenne muscular dystrophy (166)
Earnings (79108)
Editorial (4)
Employer branding (4)
Employer resources (25)
Events (95334)
Executive appointments (801)
FDA (16101)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (1087)
Gene editing (127)
Generative AI (15)
Gene therapy (348)
GLP-1 (358)
Government (1795)
Grass and pollen (3)
Guidances (330)
Healthcare (11114)
Hematology (99)
HIV (55)
Huntington's disease (23)
IgA nephropathy (65)
Immunology and inflammation (104)
Immuno-oncology (60)
Indications (169)
Infectious disease (1110)
Inflammatory bowel disease (140)
Inflation Reduction Act (4)
Influenza (93)
Intellectual property (270)
Interviews (55)
IPO (13275)
IRA (6)
Job creations (2572)
Job search strategy (369)
JPM (4)
Kidney cancer (18)
Labor market (43)
Layoffs (121)
Leadership (2)
Legal (5914)
Licensing (8)
Liver cancer (51)
Longevity (17)
Lung cancer (547)
Lymphoma (260)
Machine learning (34)
Management (5)
Manufacturing (649)
Marketing (9)
MASH (125)
Medical device (13728)
Medtech (13936)
Mergers & acquisitions (16118)
Metabolic disorders (832)
mRNA (58)
Multiple sclerosis (122)
NASH (6)
Neurodegenerative disease (236)
Neuropsychiatric disorders (41)
Neuroscience (2049)
Neurotech (1)
NextGen: Class of 2026 (3853)
Non-profit (1156)
Now hiring (15)
Obesity (258)
Opinion (37)
Ovarian cancer (170)
Pain (203)
Pancreatic cancer (235)
Parkinson's disease (233)
Partnered (17)
Patents (516)
Patient recruitment (581)
Peanut (34)
People (45531)
Pharmaceutical (32)
Pharmacy benefit managers (10)
Phase 1 (16023)
Phase 2 (22254)
Phase 3 (15398)
Pipeline (8188)
Policy (38)
Postmarket research (1777)
Preclinical (6740)
Press Release (37)
Prostate cancer (224)
Psychedelics (7)
Radiopharmaceuticals (223)
Rare diseases (605)
Real estate (3685)
Recruiting (9)
Regulatory (18400)
Reports (28)
Research institute (831)
Resumes & cover letters (60)
Rett syndrome (42)
RNA editing (5)
RSV (52)
Schizophrenia (105)
Series A (173)
Series B (150)
Service/supplier (6)
Sickle cell disease (64)
Special edition (6)
Spinal muscular atrophy (93)
Sponsored (15)
Startups (2506)
Stomach cancer (3)
Supply chain (62)
Tariffs (5)
The Weekly (1)
Vaccines (367)
Venture capital (31)
Weight loss (94)
Women's health (95)
Date
Today (50)
Last 7 days (245)
Last 30 days (1722)
Last 365 days (21169)
2026 (13779)
2025 (21286)
2024 (25426)
2023 (29437)
2022 (38805)
2021 (41597)
2020 (38383)
2019 (28437)
2018 (21543)
2017 (22759)
2016 (22152)
2015 (28356)
2014 (24730)
2013 (21136)
2012 (23468)
2011 (23614)
2010 (22884)
Location
Africa (346)
Alabama (77)
Alaska (3)
Arizona (333)
Arkansas (11)
Asia (23901)
Australia (3009)
California (12584)
Canada (3358)
China (631)
Colorado (551)
Connecticut (481)
Delaware (223)
Europe (38174)
Florida (1963)
Georgia (407)
Hawaii (3)
Idaho (48)
Illinois (827)
India (58)
Indiana (403)
Iowa (19)
Japan (447)
Kansas (109)
Kentucky (33)
Louisiana (40)
Maine (32)
Maryland (1424)
Massachusetts (8310)
Michigan (330)
Minnesota (680)
Mississippi (7)
Missouri (103)
Montana (22)
Nebraska (19)
Nevada (127)
New Hampshire (75)
New Jersey (2835)
New Mexico (17)
New York (3002)
North Carolina (1470)
North Dakota (5)
Northern California (6220)
Ohio (312)
Oklahoma (22)
Oregon (23)
Pennsylvania (2366)
Puerto Rico (24)
Rhode Island (37)
South America (543)
South Carolina (80)
South Dakota (1)
Southern California (5268)
Tennessee (150)
Texas (2039)
United States (41781)
Utah (388)
Vermont (2)
Virginia (175)
Washington D.C. (49)
Washington State (986)
West Virginia (2)
Wisconsin (95)
Wyoming (1)
552,178 Results for "908 devices inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
908 Devices to Report Second Quarter 2026 Financial Results on August 11, 2026
July 28, 2026
·
1 min read
Sponsored
How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and Medicine
As AI-enabled Software as Medical Devices become more prevalent, regulatory agencies are responding with new guidelines and AI-specific authorisation routes. This article looks at current trends, suggests clinical considerations for medical device developers and anticipates AI-enabled SaMDs’ future progress.
August 17, 2026
·
6 min read
·
JoAnne Bronikowski
Genetown
908 Devices to Participate in Upcoming Investor Conferences - May 15, 2024
908 Devices Inc. today announced it will participate in the following investor conferences.
May 15, 2024
·
1 min read
Genetown
908 Devices Announces MX908 Integration Capabilities
908 Devices Inc. announced that it has expanded access to its leading trace detection technology in its handheld MX908 device through the addition of a weatherproof, digital communications port, thereby enabling companies to integrate the device into their systems to enhance the safety of their users and the public.
November 14, 2023
·
5 min read
Press Releases
908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025
July 23, 2025
·
1 min read
Press Releases
908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook
August 6, 2025
·
12 min read
Press Releases
908 Devices Appoints Christopher D. Brown to its Board of Directors
June 16, 2025
·
3 min read
Genetown
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats.
March 12, 2024
·
5 min read
Genetown
908 Devices to Participate in Upcoming Investor Conferences - February 22, 2024
908 Devices Inc. today announced it will participate in the following investor conferences.
February 22, 2024
·
1 min read
Business
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook.
April 30, 2024
·
7 min read
1 of 55,218
Next
